Transformative Research in Diabetic Nephropathy (TRIDENT)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02986984 |
Recruitment Status :
Recruiting
First Posted : December 8, 2016
Last Update Posted : January 9, 2024
|
Sponsor:
University of Pennsylvania
Collaborators:
MOUNT SINAI HOSPITAL
University of North Carolina
Northwestern University
University of New Mexico
Stanford University
The University of Texas Health Science Center at San Antonio
Ohio State University
Yale University
Albert Einstein College of Medicine
Oregon Health and Science University
Lehigh Valley Health Network
University of Arkansas
University of Southern California
University of Virginia
Regeneron Pharmaceuticals
Boehringer Ingelheim
GlaxoSmithKline
Gilead Sciences
Juvenile Diabetes Research Foundation
Novo Nordisk A/S
Information provided by (Responsible Party):
University of Pennsylvania
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Recruiting |
---|---|
Estimated Primary Completion Date : | December 2024 |
Estimated Study Completion Date : | June 2025 |
Publications of Results:
Other Publications:
Other Publications: